Dr. Qingguo Li 李清国
Chief Physician, Associate Professor
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive colorectal cancer treatment, including minimally invasive surgery, sphincter-preserving surgery for low rectal cancer, and multidisciplinary care for liver and lung metastases. Also treats locally advanced, early-stage, rare colorectal tumors, and provides personalized care for elderly patients.
Dr. Li is a Chief Physician and Associate Professor in the Department of Colorectal Surgery at Fudan University Shanghai Cancer Center. Dr. Li serves as a supervisor for master’s and doctoral students in surgical oncology.
Professional roles
- Secretary-General and Member, Gastrointestinal Tumor Laparoscopy Professional Committee, Shanghai Anti-Cancer Association
- Chair, Youth Committee, Gastrointestinal Tumor Laparoscopy Professional Committee, Shanghai Anti-Cancer Association
- Secretary-General and Member, Comprehensive Treatment of Colorectal Cancer Professional Committee, Chinese Medical Doctor Association
- Member, Rectal Cancer Prevention and Treatment Expert Committee, General Surgery Professional Committee, China Association of Integrative Medicine
Name order: in Chinese the family name comes first (Li Qingguo). Papers usually list the name as Qingguo Li or Li Q.
Selected publications
142 papers on PubMed matched by name and affiliation; 22 as first or senior author since 2016. Most recent first- or senior-author papers:
- Semin Oncol, 2026 (senior author): From imaging to action: MRI features direct surgical strategy in low rectal cancer. PubMed 42492411
- Surg Endosc, 2026 (senior author): Shifting paradigms in 30,427 surgical colorectal cancer cases (2008-2023): the impact of endoscopic screening on caseload complexity and the value of minimally invasive quality. PubMed 42257954
- Biochim Biophys Acta Rev Cancer, 2025 (senior author): Targetable axes of tumor-associated macrophages: An MSF framework for precision immunotherapy. PubMed 40997958
- Nat Cancer, 2025 (first author): Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer. PubMed 39966610
- J Exp Clin Cancer Res, 2021 (first author): Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. PubMed 34740372
- Int J Cancer, 2021 (senior author): Novel functional variants in the Notch pathway and survival of Chinese colorectal cancer. PubMed 33728681
- Front Cell Dev Biol, 2021 (senior author): Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer. PubMed 34211976
- Front Public Health, 2020 (first author): Changes in Incidence and Survival by Decade of Patients With Primary Colorectal Lymphoma: A SEER Analysis. PubMed 33178655
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion